Brian Burke

Title: Brian Burke: Innovator in Ocular Drug Delivery

Introduction

Brian Burke is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of pharmaceutical formulations. He holds a total of 5 patents, showcasing his innovative approach to drug delivery systems, particularly in ocular treatments.

Latest Patents

Among his latest patents, Burke has developed injectable triamcinolone formulations. This patent relates to pharmaceutical suspensions of triamcinolone acetonide, detailing methods for producing stable suspensions suitable for administration via suprachoroidal injection through a 30-gauge microneedle. Another significant patent focuses on methods and devices for the treatment of ocular diseases in human subjects. This invention provides targeted non-surgical administration of a drug formulation to the suprachoroidal space of the eye, aimed at treating posterior ocular disorders or choroidal maladies. The method involves inserting a hollow microneedle into the eye and infusing a drug formulation that flows within the suprachoroidal space during the infusion.

Career Highlights

Brian Burke is currently associated with Clearside Biomedical, Inc., where he continues to advance his research and development efforts in ocular drug delivery. His work has significantly impacted the way ocular diseases are treated, providing new avenues for effective therapies.

Collaborations

Burke collaborates with notable colleagues, including Vladimir Zarnitsyn and Daniel White, who contribute to the innovative environment at Clearside Biomedical, Inc. Their combined expertise fosters advancements in the field of ocular therapeutics.

Conclusion

Brian Burke's innovative work in ocular drug delivery exemplifies the importance of research and development in improving treatment options for patients. His patents reflect a commitment to enhancing pharmaceutical formulations and methodologies, making a significant impact in the medical field.